Figure 1: Increase in size of the right arm of our patient due to deep vein thrombosis.
Figure 2: Acute thrombotic occlusion of the subclavian vein.
Figure 3: Acute thrombotic occlusion of the axillary vein.
Figure 4: Revascularization anterior to the thrombosed subclavian vein.
Figure 5: Revascularization posterior to the thrombosed axillary vein.
The patient was kept on warfarin sodium anticoagulation therapy for six months, and INR levels of 2.2±0.2 were targeted. Her outpatient follow-up continues free of events with only oral medication of 300 mg acetylsalicylate per day. She is asymptomatic, and there has been no recurrence or post-thrombotic sequelae.
In the retrospective study by Rosenwasser et al.,[4] 630 Swan-Ganz catheters were placed in 184 patients. An evaluation of complications demonstrated a 1.3% incidence of subclavian vein thrombosis (8 of 630 catheters).
Forty-four patients received jugular bulb catheter monitoring in the intensive care unit (ICU) in a study by Coplin et al.[5] In 20 randomly chosen patients, an ultrasonographic evaluation was performed after removal of the catheter for an assessment of internal jugular vein thrombosis. Of these 20 patients, eight (40%) had nonobstructive, subclinical internal jugular vein thrombi after jugular bulb catheter monitoring (95% confidence interval, 19-61%). The median monitoring duration was three days (range, 1-6 days). No clinical factor was identified to be associated with thrombus formation.[5]
In the study by Timsit et al.,[6] 265 internal jugular or subclavian catheters were included in ICU patients. Veins were explored by duplex scanning performed just before catheter removel or <24 hours afterwards. Two hundred and eight catheters were analyzed, and a catheter-related internal jugular or subclavian vein thrombosis occurred in 33% of the cases. Thrombosis was limited in 8%, large in 22%, and occlusive in 3% of the cases. The internal jugular route, therapeutic heparinization, and age >64 years were independently associated with catheter-related thrombosis.[6] Our case possessed all these characteristics. The right internal jugular vein was the insertion site of the catheter in our case as well, and the thrombosis that developed was occlusive in character. Additionally, the lack of prophylactic heparin use and the patient's advanced age of 73-years-old were the other remarkable factors.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect
to the authorship and/or publication of this article.
Funding
The authors received no financial support for the
research and/or authorship of this article.
1) Karahan N, Yetkin U, Yakut N, Adanır T, Aksun M, Bayrak
S, et al. Approach to Swan Ganz thermodilution catheter
complications: 6 years experience with 2310 cases. Internet J
Thorac Cardiovasc Surg 2008;11:20.
2) Bassi IM, Lazzari C, Zanela T. The basic ideas about the use of the Swan-Ganz catheter. Rev Gaucha Enferm 1990;11:52-
7) [Abstract]
3) Ayalon A, Cohen O, Charuzi I, Schiller M. Central
vein thrombosis: a complication of internal jugular vein
cannulation. Infusionsther Klin Ernahr 1979;6:265-7.
4) Rosenwasser RH, Jallo JI, Getch CC, Liebman KE.
Complications of Swan-Ganz catheterization for
hemodynamic monitoring in patients with subarachnoid
hemorrhage. Neurosurgery 1995;37:872-5.